Abstract:Introduction: Patients with chronic HBV infection (CHI) exhibit defective anti-viral immune-response whose underlying causes still remain unclear. Monocytes act as immune sentinels for pathogens and can regulate immunity via interaction with other immune-cells, apart from differentiating into macrophages. Immune-checkpoint molecules (ICMs) expressed by immune-cells, including monocytes are known to negatively regulate immune-responses. Here, we evaluated the expression of ICMs, namely, Gal-9, PD-L1, and CTLA-4 on monocytes in different phases of CHI, identified the viral and the host factors causing their aberrant expression and investigated their impact during interaction of monocytes with T-cells, B-cells and NK-cells and also on monocyte to macrophage differentiation. Influence of Tenofovir therapy on the expression of monocytic ICMs was also studied. Methods: Collection of blood and liver-tissue samples from HBV infected patients and controls, flow-cytometry, cell sorting, cell culture and immune-fluorescence were performed for this study. Results: Gal-9 + and PD-L1 + -monocytes were significantly increased in HBeAg-positive as well as HBeAg-negative chronic hepatitis B (CHB) patients than healthy controls (HC). In immune-tolerant (IT) subjects, only Gal-9 + -monocytes and in inactive carriers (IC), PD-L1 + -monocytes were higher than HC while CTLA-4 + -monocytes remained comparable among groups. High serum Hepatitis B surface antigen (HBsAg) concentration in CHB as well as IT and TNF-α in CHB triggered monocytic Gal-9-expression whereas, PD-L1 was induced by elevated TNF-α and IL-4 in CHB and IL-1β in CHB and IC. Purified monocytes from CHB and IT having high Gal-9 expression led to expansion of CD4 + CD25 + FOXP3 + -Tregs, CD19 + IL-10 + -Bregs and CD19 + CD27 - CD21 – atypical memory B-cells and these monocytes also preferentially differentiated into M2-macrophages. These phenomena were reversed by anti-Gal-9-antibody. Parallelly, PD-L1 + -monocytes in CHB and IC reduced IL-2/IFN-γ and IL-6 production by HBV-specific T- and B-cells respectively, which were restored by anti-PD-L1-antibody. Both Gal-9 + - and PD-L1 + -monocytes caused decline in IFN-γ + -NK-cells but enhanced IL-10-expressing HBV-specific-T-cells and NK-cells. Increased intrahepatic CD14 + Gal-9 + and CD14 + PD-L1 + -monocytes were noted in CHB patients than HC. One-year tenofovir therapy failed to reduce monocytic Gal-9 and PD-L1 along with the levels of HBsAg, TNF-α, IL-1β and IL-4. Conclusions: Monocytic Gal-9 and PD-L1, expressed heterogeneously in different phases of CHI, exert diverse inhibitory effects on immune-responses and their therapeutic targeting could boost anti-HBV immunity.

Monocyte-derived Galectin-9 and PD-L1 differentially impair adaptive and innate immune response in chronic HBV infection and their expression remain unaltered after antiviral therapy

Increasing LAG-3 expression suppresses T-cell function in chronic hepatitis B: A balance between immunity strength and liver injury extent.

Increasing LAG-3 Expression Suppresses T-cell Function in Chronic Hepatitis B

Natural Killer Cells Induce CD8+ T Cell Dysfunction via Galectin-9/TIM-3 in Chronic Hepatitis B Virus Infection

Monocyte Transcriptome in Different Phases of Chronic Hepatitis B Virus Infection Uncovers Potential Functional Roles

Regulatory NK Cells Mediated Between Immunosuppressive Monocytes and Dysfunctional T Cells in Chronic HBV Infection

Cytokine profiles and virological markers highlight distinctive immune statuses, and effectivenesses and limitations of NAs across different courses of chronic HBV infection

IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection.

Longitudinal Fluctuations in PD1 and PD-L1 Expression in Association with Changes in Anti-Viral Immune Response in Chronic Hepatitis B

Effects of Regulatory T Cells on Anti-Viral Immune Responses Impaired by Chronic Hepatitis B

The expressions of PD-1 and PD-L1 and the correlation with the degree of liver damage in HBV chronic infection

Hepatitis B Virus–Induced Imbalance of Inflammatory and Antiviral Signaling by Differential Phosphorylation of STAT1 in Human Monocytes

Modulation of Monocyte Activity by Hepatocellular MicroRNA Delivery Via Hepatitis B Virus Surface Antigen Particles: Implications for Pathobiology of Chronic Hepatitis B

Decrease of CD69 levels on TCR Vα7.2+CD4+ innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients

Regulation of HBV-specific CD8+ T cell-mediated inflammation is diversified in different clinical presentations of HBV infection

Chronic Viral Infection Compromises the Quality of Circulating Mucosal–Associated Invariant T Cells and Follicular T Helper Cells via Expression of Inhibitory Receptors

Circulating Cd4(+)Cd25(High) Regulatory T Cells And Expression Of Pd-1 And Btla On Cd4(+) T Cells In Patients With Chronic Hepatitis B Virus Infection

B7-H1 Expression is Up-Regulated in Peripheral Blood Cd14+Monocytes of Patients with Chronic Hepatitis B Virus Infection, Which Correlates with Higher Serum Il-10 Levels

Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14 Monocytes and CD19 B Cells with the Progression of Hepatitis B Virus Infection.

Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection

HBsAg Inhibits IFN-α Production in Plasmacytoid Dendritic Cells Through TNF-α and IL-10 Induction in Monocytes.